Journal of the American Society of Nephrology : JASN · 2026
Fibroblast COX-2 Expression in the Development of Progressive Kidney Fibrosis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tsai Ming-Tsun, Jiang Mengdi, Pan Yu, Cao Shirong, Wang Yinqiu, Chen Jianchun, Li Shensen, Dong Xinyu, Luo Wentian, Fogo Agnes B, Zent Roy, Wilson Matthew H, Arroyo Ornelas Juan Pablo, Terker Andrew S, Zhang Ming-Zhi, Harris Raymond C
Аннотация
BACKGROUND: During progressive kidney injury, pericytes and resident fibroblasts migrate, proliferate and differentiate into myofibroblasts, which are the major source of extracellular matrix deposition. Both interstitial fibroblasts and macrophages contribute to kidney fibrosis and coexist within the fibrotic niche. However, the potential interaction between fibroblasts and macrophages and its role in kidney fibrosis remains incompletely understood. Previous studies have indicated a role for kidney prostaglandins to limit fibroblast activity and myofibroblast transformation.
METHODS: Inducible PDGFRß-Cre mice were crossed to the indicated floxed mice to selectively delete either cyclooxygenase 2 (COX-2) or the PGE2 receptors EP2 and EP4. Unilateral ureteral obstruction was utilized as a model of progressive kidney fibrosis.
RESULTS: Selective deletion of cyclooxygenase-2 expression in fibroblasts (FibCOX-2-/-) increased kidney fibrosis in association with kidney macrophages with a proinflammatory and profibrotic phenotype. The highest differentially expressed gene in these macrophages was the profibrotic factor SPP1/osteopontin, and deletion of kidney macrophages with clodronate inhibited kidney expression of SPP1 and ameliorated fibrosis in FibCOX2-/- mice.
CONCLUSIONS: Our findings suggest that fibroblast COX-2 protects against progressive kidney fibrosis, potentially through a regulatory interplay that modulates the surrounding macrophage phenotype during chronic kidney injury.
METHODS: Inducible PDGFRß-Cre mice were crossed to the indicated floxed mice to selectively delete either cyclooxygenase 2 (COX-2) or the PGE2 receptors EP2 and EP4. Unilateral ureteral obstruction was utilized as a model of progressive kidney fibrosis.
RESULTS: Selective deletion of cyclooxygenase-2 expression in fibroblasts (FibCOX-2-/-) increased kidney fibrosis in association with kidney macrophages with a proinflammatory and profibrotic phenotype. The highest differentially expressed gene in these macrophages was the profibrotic factor SPP1/osteopontin, and deletion of kidney macrophages with clodronate inhibited kidney expression of SPP1 and ameliorated fibrosis in FibCOX2-/- mice.
CONCLUSIONS: Our findings suggest that fibroblast COX-2 protects against progressive kidney fibrosis, potentially through a regulatory interplay that modulates the surrounding macrophage phenotype during chronic kidney injury.